Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seohung is a leading global manufacturer of hard capsules and a prominent provider of contract manufacturing and development services (CDMO) for the pharmaceutical and nutraceutical industries. Founded in 1973 and headquartered in South Korea, the company specializes in the production of high-quality gelatin and vegetable-based (HPMC) capsules, as well as softgels, tablets, and liquid formulations. Seohung operates state-of-the-art manufacturing facilities across South Korea, Vietnam, and the United States, serving a diverse international pharmaceutical and health supplement clientele. In addition to its core capsule business, the company is a major player in the health functional food market, offering end-to-end solutions from formulation to packaging. The company is recognized as one of the top three hard capsule manufacturers globally, competing on the basis of its proprietary technology and high-volume production capacity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seohung.